The insurability of innovative pharmaceutical cancer technologies

Abstract The scientific literature, including several papers published in the IJHPR, has raised the issue of the spiraling cost of cancer treatment, including that of cancer drugs and other technologies such as gene and cell therapies. In this perspective, we review three criteria for insurability a...

Full description

Saved in:
Bibliographic Details
Main Authors: Shuli Brammli Greenberg (Author), Einat Dotan (Author), Rachel Arazi (Author)
Format: Book
Published: BMC, 2020-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available